HCM
COCH icon

Highbridge Capital Management’s Envoy Medical COCH Stock Holding History

Highbridge Capital Management’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-300,403
Closed -$2.95M – 538
2022
Q3 		$2.95M Buy
+300,403
New +$2.95M 0.04% 301

Other funds holding COCH

AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return

Highbridge Capital Management's COCH Position: Q4 2022 in Review

Highbridge Capital Management sold out of Envoy Medical (COCH) in Q4 2022, closing a stake of 300,403 shares — an estimated $2.95M sold.

Highbridge Capital Management first reported a position in COCH in Q3 2022 and held it in 1 quarter. The position peaked at $2.95M in Q3 2022. 93 funds tracked by Wall St. Rank hold COCH as of Q4 2022.

  • Highbridge Capital Management reported no remaining Envoy Medical position as of Q4 2022 after selling out during the quarter.
  • Highbridge Capital Management sold 300,403 Envoy Medical shares in Q4 2022, an estimated $2.95M.
  • Highbridge Capital Management first reported a position in Envoy Medical in Q3 2022 and held it in 1 quarter.
  • Highbridge Capital Management's Envoy Medical position peaked at $2.95M in Q3 2022.
  • 93 funds tracked by Wall St. Rank held Envoy Medical as of Q4 2022.

Based on Highbridge Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.